Strata Critical Medical (SRTA) Non-Current Deffered Revenue (2019 - 2021)

Strata Critical Medical (SRTA) has 3 years of Non-Current Deffered Revenue data on file, last reported at $9.6 million in Q1 2021.

• Quarterly Non-Current Deffered Revenue changed 0.0% year-over-year to $9.6 million in Q1 2021, while the trailing twelve-month figure through Mar 2021 was $9.6 million (changed 0.0% YoY) and the FY2020 annual result came in at $9.6 million, changed N/A from the prior year.
• Non-Current Deffered Revenue held at $9.6 million in Q1 2021 per SRTA's latest filing, from $9.6 million in the prior quarter.
• Across five years, Non-Current Deffered Revenue topped out at $9.6 million in Q3 2019 and bottomed at $9.6 million in Q3 2019.
• The 3-year median for Non-Current Deffered Revenue is $9.6 million (2019), against an average of $9.6 million.
• Peak annual rise in Non-Current Deffered Revenue reached 0.0% in 2020, while the deepest fall reached 0.0% in 2020.
• Tracing SRTA's Non-Current Deffered Revenue over 3 years: stood at $9.6 million in 2019, then changed by 0.0% to $9.6 million in 2020, then changed by 0.0% to $9.6 million in 2021.
• Per Business Quant, the three latest SRTA Non-Current Deffered Revenue figures stand at $9.6 million (Q1 2021), $9.6 million (Q4 2020), and $9.6 million (Q3 2020).

Peer Comparison